H5Health Limited 10706231 false 2025-05-01 2026-04-30 2026-04-30 The principal activity of the company is medical services. Digita Accounts Production Advanced 6.30.9574.0 true 10706231 2025-05-01 2026-04-30 10706231 2026-04-30 10706231 core:RetainedEarningsAccumulatedLosses 2026-04-30 10706231 core:ShareCapital 2026-04-30 10706231 core:CurrentFinancialInstruments core:WithinOneYear 2026-04-30 10706231 bus:SmallEntities 2025-05-01 2026-04-30 10706231 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 10706231 bus:FullAccounts 2025-05-01 2026-04-30 10706231 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 10706231 bus:RegisteredOffice 2025-05-01 2026-04-30 10706231 bus:Director1 2025-05-01 2026-04-30 10706231 bus:Director2 2025-05-01 2026-04-30 10706231 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 10706231 core:PlantMachinery 2025-05-01 2026-04-30 10706231 countries:EnglandWales 2025-05-01 2026-04-30 10706231 2024-05-01 2025-04-30 10706231 2025-04-30 10706231 core:RetainedEarningsAccumulatedLosses 2025-04-30 10706231 core:ShareCapital 2025-04-30 10706231 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 iso4217:GBP xbrli:pure

Registration number: 10706231

H5Health Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2026

 

H5Health Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

H5Health Limited

(Registration number: 10706231)
Abridged Balance Sheet as at 30 April 2026

2026
£

2025
£

Fixed assets

Tangible assets

164

-

Current assets

Cash at bank and in hand

17,669

13,227

Creditors: Amounts falling due within one year

(8,956)

(9,238)

Net current assets

8,713

3,989

Net assets

8,877

3,989

Capital and reserves

Called up share capital

1

1

Profit and loss account

8,876

3,988

Total equity

8,877

3,989

For the financial year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 20 August 2026 and signed on its behalf by:
 

Dr C Murdoch

Director

Mrs R Murdoch

Director

 

H5Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2026

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Ling Heather
The Street
Farmborough
Bath
Somerset
BA2 0AR

These financial statements were authorised for issue by the Board on 20 August 2026.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

H5Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2026

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

20% Reducing balance

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

4

Tangible assets

Total
£

Cost or valuation

Additions

205

At 30 April 2026

205

Depreciation

Charge for the year

41

At 30 April 2026

41

Carrying amount

At 30 April 2026

164